Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Steinberg

Showing results (901-910 of 944) with videos related to

Pageof 95
Sort By:
Urologic Oncology|January 24, 2021
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysisVignesh T Packiam, Craig V Labbate, Stephen A Boorjian, et al.
Investigative Ophthalmology & Visual Science|August 30, 2011
Retinal disease course in Usher syndrome 1B due to MYO7A mutationsSamuel G Jacobson, Artur V Cideciyan, Dan Gibbs, et al.
Investigative Ophthalmology & Visual Science|February 28, 2007
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsTomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.
Urologic Oncology|November 18, 2018
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigationAnirban P Mitra, Adrian S Fairey, Eila C Skinner, et al.
World Journal of Urology|June 26, 2016
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancerM N Pham, A B Apolo, M De Santis, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Scientific Reports|October 25, 2016
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder CancersK B Skowron, S P Pitroda, J P Namm, et al.
Pageof 95

Showing results (901-910 of 944) with videos related to

Sort By:
Pageof 95
Urologic Oncology|January 24, 2021
The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysisVignesh T Packiam, Craig V Labbate, Stephen A Boorjian, et al.
Investigative Ophthalmology & Visual Science|August 30, 2011
Retinal disease course in Usher syndrome 1B due to MYO7A mutationsSamuel G Jacobson, Artur V Cideciyan, Dan Gibbs, et al.
Investigative Ophthalmology & Visual Science|February 28, 2007
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerationsTomas S Aleman, Artur V Cideciyan, Elizabeth A M Windsor, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancerMatthew D Galsky, Arjun V Balar, Peter C Black, et al.
Urologic Oncology|November 18, 2018
Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigationAnirban P Mitra, Adrian S Fairey, Eila C Skinner, et al.
World Journal of Urology|June 26, 2016
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancerM N Pham, A B Apolo, M De Santis, et al.
Nature Reviews. Urology|September 10, 2025
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapiesLexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess, et al.
Scientific Reports|October 25, 2016
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder CancersK B Skowron, S P Pitroda, J P Namm, et al.
Pageof 95